Remove Cell Biology Remove Pharmaceuticals Remove Protein Expression Remove Protein Production
article thumbnail

What to expect from PEGS Europe 2023: Day 1

Drug Discovery World

Presentations that follow include: Andres Perez Bay, PhD, Senior Staff Scientist, Oncology & Angiogenesis, Regeneron Pharmaceuticals, on: ‘A bispecific METxMET antibody-drug conjugate with cleavable linker is processed in recycling and late endosomes’. The presentations which follow include: Peter Tessier, PhD, Albert M.

article thumbnail

What to expect from PEGS Europe 2023: Day 3

Drug Discovery World

Respectively, they will be moderated by Karoline Bechtold-Peters, PhD, Senior Strategy & Technology Leader, Pharmaceuticals & Biopharma Process, Novartis Pharma, and Bernhard Valldorf, PhD, Targeting Director, Targeted mRNA Delivery, EMD Serono.